Selected research
Industry Research
Gene Cloning Service Industry Research Report 2026
Market perspective
The global Gene Cloning Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Gene Cloning Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Gene Cloning Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Gene Cloning Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Gene Cloning Service include Thermo Fisher Scientific Inc., Eurofins Scientific, GenScript, Merck KGaA, Takara Bio Inc., Charles River Laboratories, Lonza, Sartorius AG and Creative Biogene, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Gene Cloning Service market in terms of revenue (US$ million) and, where applicable, service volume (Unit), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Unit) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Gene Cloning Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gene Cloning Service Market by Company
Thermo Fisher Scientific Inc.
Eurofins Scientific
GenScript
Merck KGaA
Takara Bio Inc.
Charles River Laboratories
Lonza
Sartorius AG
Creative Biogene
Cellecta, Inc.
Synbio Technologies
TransGen Biotech Co., Ltd.
Dobuss(Canvax)
Azenta US, Inc.
Macrogen, Inc.
Codex DNA, Inc.
Gene Cloning Service Segment by Type
Stranded Gene
Complex Gene
Others
Gene Cloning Service Segment by Application
Gene Synthesis
Gene Expression
Gene Therapy
Vaccine Research
Others
Gene Cloning Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Cloning Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Cloning Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Cloning Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Gene Cloning Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stranded Gene
- Complex Gene
- Others
Applications
- Gene Synthesis
- Gene Expression
- Gene Therapy
- Vaccine Research
- Others
Companies covered
- Thermo Fisher Scientific Inc.
- Eurofins Scientific
- GenScript
- Merck KGaA
- Takara Bio Inc.
- Charles River Laboratories
- Lonza
- Sartorius AG
- Creative Biogene
- Cellecta, Inc.
- Synbio Technologies
- TransGen Biotech Co., Ltd.
- Dobuss(Canvax)
- Azenta US, Inc.
- Macrogen, Inc.
- Codex DNA, Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Gene Cloning Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Stranded Gene
- 2.2.3 Complex Gene
- 2.2.4 Others
- 2.3 Gene Cloning Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Gene Synthesis
- 2.3.3 Gene Expression
- 2.3.4 Gene Therapy
- 2.3.5 Vaccine Research
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Gene Cloning Service Breakdown Data by Type
- 3.1 Global Gene Cloning Service Historic Market Size by Type (2021-2026)
- 3.2 Global Gene Cloning Service Forecasted Market Size by Type (2027-2032)
4 Gene Cloning Service Breakdown Data by Application
- 4.1 Global Gene Cloning Service Historic Market Size by Application (2021-2026)
- 4.2 Global Gene Cloning Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Gene Cloning Service Market Perspective (2021-2032)
- 5.2 Global Gene Cloning Service Growth Trends by Region
- 5.2.1 Global Gene Cloning Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Gene Cloning Service Historic Market Size by Region (2021-2026)
- 5.2.3 Gene Cloning Service Forecasted Market Size by Region (2027-2032)
- 5.3 Gene Cloning Service Market Dynamics
- 5.3.1 Gene Cloning Service Industry Trends
- 5.3.2 Gene Cloning Service Market Drivers
- 5.3.3 Gene Cloning Service Market Challenges
- 5.3.4 Gene Cloning Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Gene Cloning Service Players by Revenue
- 6.1.1 Global Top Gene Cloning Service Players by Revenue (2021-2026)
- 6.1.2 Global Gene Cloning Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Gene Cloning Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Gene Cloning Service Head Office and Area Served
- 6.4 Global Gene Cloning Service Players, Product Type & Application
- 6.5 Global Gene Cloning Service Manufacturers Established Date
- 6.6 Global Gene Cloning Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Gene Cloning Service Market Size (2021-2032)
- 7.2 North America Gene Cloning Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Gene Cloning Service Market Size by Country (2021-2026)
- 7.4 North America Gene Cloning Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Gene Cloning Service Market Size (2021-2032)
- 8.2 Europe Gene Cloning Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Gene Cloning Service Market Size by Country (2021-2026)
- 8.4 Europe Gene Cloning Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Gene Cloning Service Market Size (2021-2032)
- 9.2 Asia-Pacific Gene Cloning Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Gene Cloning Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Gene Cloning Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Gene Cloning Service Market Size (2021-2032)
- 10.2 South America Gene Cloning Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Gene Cloning Service Market Size by Country (2021-2026)
- 10.4 South America Gene Cloning Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Gene Cloning Service Market Size (2021-2032)
- 11.2 Middle East & Africa Gene Cloning Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Gene Cloning Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Gene Cloning Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific Inc.
- 12.1.1 Thermo Fisher Scientific Inc. Company Information
- 12.1.2 Thermo Fisher Scientific Inc. Business Overview
- 12.1.3 Thermo Fisher Scientific Inc. Revenue in Gene Cloning Service Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Inc. Gene Cloning Service Product Portfolio
- 12.1.5 Thermo Fisher Scientific Inc. Recent Developments
- 12.2 Eurofins Scientific
- 12.2.1 Eurofins Scientific Company Information
- 12.2.2 Eurofins Scientific Business Overview
- 12.2.3 Eurofins Scientific Revenue in Gene Cloning Service Business (2021-2026)
- 12.2.4 Eurofins Scientific Gene Cloning Service Product Portfolio
- 12.2.5 Eurofins Scientific Recent Developments
- 12.3 GenScript
- 12.3.1 GenScript Company Information
- 12.3.2 GenScript Business Overview
- 12.3.3 GenScript Revenue in Gene Cloning Service Business (2021-2026)
- 12.3.4 GenScript Gene Cloning Service Product Portfolio
- 12.3.5 GenScript Recent Developments
- 12.4 Merck KGaA
- 12.4.1 Merck KGaA Company Information
- 12.4.2 Merck KGaA Business Overview
- 12.4.3 Merck KGaA Revenue in Gene Cloning Service Business (2021-2026)
- 12.4.4 Merck KGaA Gene Cloning Service Product Portfolio
- 12.4.5 Merck KGaA Recent Developments
- 12.5 Takara Bio Inc.
- 12.5.1 Takara Bio Inc. Company Information
- 12.5.2 Takara Bio Inc. Business Overview
- 12.5.3 Takara Bio Inc. Revenue in Gene Cloning Service Business (2021-2026)
- 12.5.4 Takara Bio Inc. Gene Cloning Service Product Portfolio
- 12.5.5 Takara Bio Inc. Recent Developments
- 12.6 Charles River Laboratories
- 12.6.1 Charles River Laboratories Company Information
- 12.6.2 Charles River Laboratories Business Overview
- 12.6.3 Charles River Laboratories Revenue in Gene Cloning Service Business (2021-2026)
- 12.6.4 Charles River Laboratories Gene Cloning Service Product Portfolio
- 12.6.5 Charles River Laboratories Recent Developments
- 12.7 Lonza
- 12.7.1 Lonza Company Information
- 12.7.2 Lonza Business Overview
- 12.7.3 Lonza Revenue in Gene Cloning Service Business (2021-2026)
- 12.7.4 Lonza Gene Cloning Service Product Portfolio
- 12.7.5 Lonza Recent Developments
- 12.8 Sartorius AG
- 12.8.1 Sartorius AG Company Information
- 12.8.2 Sartorius AG Business Overview
- 12.8.3 Sartorius AG Revenue in Gene Cloning Service Business (2021-2026)
- 12.8.4 Sartorius AG Gene Cloning Service Product Portfolio
- 12.8.5 Sartorius AG Recent Developments
- 12.9 Creative Biogene
- 12.9.1 Creative Biogene Company Information
- 12.9.2 Creative Biogene Business Overview
- 12.9.3 Creative Biogene Revenue in Gene Cloning Service Business (2021-2026)
- 12.9.4 Creative Biogene Gene Cloning Service Product Portfolio
- 12.9.5 Creative Biogene Recent Developments
- 12.10 Cellecta, Inc.
- 12.10.1 Cellecta, Inc. Company Information
- 12.10.2 Cellecta, Inc. Business Overview
- 12.10.3 Cellecta, Inc. Revenue in Gene Cloning Service Business (2021-2026)
- 12.10.4 Cellecta, Inc. Gene Cloning Service Product Portfolio
- 12.10.5 Cellecta, Inc. Recent Developments
- 12.11 Synbio Technologies
- 12.11.1 Synbio Technologies Company Information
- 12.11.2 Synbio Technologies Business Overview
- 12.11.3 Synbio Technologies Revenue in Gene Cloning Service Business (2021-2026)
- 12.11.4 Synbio Technologies Gene Cloning Service Product Portfolio
- 12.11.5 Synbio Technologies Recent Developments
- 12.12 TransGen Biotech Co., Ltd.
- 12.12.1 TransGen Biotech Co., Ltd. Company Information
- 12.12.2 TransGen Biotech Co., Ltd. Business Overview
- 12.12.3 TransGen Biotech Co., Ltd. Revenue in Gene Cloning Service Business (2021-2026)
- 12.12.4 TransGen Biotech Co., Ltd. Gene Cloning Service Product Portfolio
- 12.12.5 TransGen Biotech Co., Ltd. Recent Developments
- 12.13 Dobuss(Canvax)
- 12.13.1 Dobuss(Canvax) Company Information
- 12.13.2 Dobuss(Canvax) Business Overview
- 12.13.3 Dobuss(Canvax) Revenue in Gene Cloning Service Business (2021-2026)
- 12.13.4 Dobuss(Canvax) Gene Cloning Service Product Portfolio
- 12.13.5 Dobuss(Canvax) Recent Developments
- 12.14 Azenta US, Inc.
- 12.14.1 Azenta US, Inc. Company Information
- 12.14.2 Azenta US, Inc. Business Overview
- 12.14.3 Azenta US, Inc. Revenue in Gene Cloning Service Business (2021-2026)
- 12.14.4 Azenta US, Inc. Gene Cloning Service Product Portfolio
- 12.14.5 Azenta US, Inc. Recent Developments
- 12.15 Macrogen, Inc.
- 12.15.1 Macrogen, Inc. Company Information
- 12.15.2 Macrogen, Inc. Business Overview
- 12.15.3 Macrogen, Inc. Revenue in Gene Cloning Service Business (2021-2026)
- 12.15.4 Macrogen, Inc. Gene Cloning Service Product Portfolio
- 12.15.5 Macrogen, Inc. Recent Developments
- 12.16 Codex DNA, Inc.
- 12.16.1 Codex DNA, Inc. Company Information
- 12.16.2 Codex DNA, Inc. Business Overview
- 12.16.3 Codex DNA, Inc. Revenue in Gene Cloning Service Business (2021-2026)
- 12.16.4 Codex DNA, Inc. Gene Cloning Service Product Portfolio
- 12.16.5 Codex DNA, Inc. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst